anti-CD40/anti-TAA bispecific monoclonal antibody ABBV-428
Term · Oncology and biomedicine · MLC-T-ONC-010392
A bispecific monoclonal antibody composed of a binding domain for an epitope found on the cell-surface receptor CD40 linked to a binding domain directed to an as of yet undisclosed tumor-associated antigen (TAA), with potential immunomodulating and antineoplastic activities. Upon administration of anti-CD40/anti-TAA bispecific monoclonal antibody ABBV-428, the anti-TAA moiety targets and binds to the TAA expressed on the tumor cells. The agonistic anti-CD40 moiety targets and binds to various CD40-expressing immune cells. This leads to the activation and proliferation of effector and memory T cells, and enhances the immune response against tumor cells, which kills and inhibits the proliferation of the TAA-expressing tumor cells. CD40, a stimulatory receptor and a member of the tumor necrosis factor receptor superfamily (TNFRSF), is expressed on various immune cells, such as macrophages, B lymphocytes, and dendritic cells (DCs); it plays a key role in the activation of the immune system.
| Identifier | MLC-T-ONC-010392 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-CD40 x anti-TAA bispecific monoclonal antibody ABBV-428 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010392",
"term": "anti-CD40/anti-TAA bispecific monoclonal antibody ABBV-428",
"field": "Oncology and biomedicine",
"definition": "A bispecific monoclonal antibody composed of a binding domain for an epitope found on the cell-surface receptor CD40 linked to a binding domain directed to an as of yet undisclosed tumor-associated antigen (TAA), with potential immunomodulating and antineoplastic activities. Upon administration of anti-CD40/anti-TAA bispecific monoclonal antibody ABBV-428, the anti-TAA moiety targets and binds to the TAA expressed on the tumor cells. The agonistic anti-CD40 moiety targets and binds to various CD40-expressing immune cells. This leads to the activation and proliferation of effector and memory T cells, and enhances the immune response against tumor cells, which kills and inhibits the proliferation of the TAA-expressing tumor cells. CD40, a stimulatory receptor and a member of the tumor necrosis factor receptor superfamily (TNFRSF), is expressed on various immune cells, such as macrophages, B lymphocytes, and dendritic cells (DCs); it plays a key role in the activation of the immune system.",
"synonyms": [
"anti-CD40 x anti-TAA bispecific monoclonal antibody ABBV-428"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-cd40-anti-taa-bispecific-monoclonal-antibody-abbv-428/"
}
Record 1,480 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.